<DOC>
	<DOCNO>NCT01070355</DOCNO>
	<brief_summary>Eicosapentaenoic acid ( EPA ) naturally occur omega-3 polyunsaturated fatty acid find oily fish . EPA anti-colorectal ( bowel ) cancer activity experimental model . This trial test whether EPA reduce marker tumour growth , safe well tolerate , patient colorectal cancer liver metastases await surgery .</brief_summary>
	<brief_title>Eicosapentaenoic Acid ( EPA ) Treatment Colorectal Cancer Liver Metastases</brief_title>
	<detailed_description>A double-blind , randomise , placebo-controlled trial eicosapentaenoic acid ( EPA ) , free fatty acid form , 2g daily patient undergo liver resection surgery colorectal cancer liver metastasis .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Age great equal 18 year Either sex Liver resection deem clinically appropriate management metastatic colorectal cancer Duration decision perform liver resection surgery great 2 week Ability give write informed consent follow study protocol Telephone contact possible Neoadjuvant chemotherapy colorectal cancer ( CRC ) liver metastasis Chemotherapy cancer previous 3 month Known bleed diathesis anticoagulation therapy Fish seafood allergy Use fish oil supplement ( eg . cod liver oil ) unwilling stop duration study Pregnancy Nonaspirin nonsteroidal antiinflammatory ( NSAID ) corticosteroid use Renal impairment ( serum creatinine &gt; 150 ) Active inflammatory disease ( e.g . Inflammatory Bowel Disease , Rheumatoid Arthritis ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Fish Oils</keyword>
	<keyword>Fatty Acids , Omega-3</keyword>
	<keyword>Eicosapentaenoic Acid</keyword>
	<keyword>Liver Metastases</keyword>
	<keyword>Randomised Controlled Trial</keyword>
</DOC>